Endologix Stock Hits New 52-Week High (ELGX)

NEW YORK ( TheStreet) -- Endologix (Nasdaq: ELGX) hit a new 52-week high Friday as it is currently trading at $12.28, above its previous 52-week high of $12.20 with 368,187 shares traded as of 12:10 p.m. ET. Average volume has been 547,800 shares over the past 30 days.

Endologix has a market cap of $664.6 million and is part of the health care sector and health services industry. Shares are up 2.6% year to date as of the close of trading on Thursday.

Endologix, Inc. develops, manufactures, markets, and sells devices for treatments of aortic disorders.

TheStreet Ratings rates Endologix as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full Endologix Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio